Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Intradialytic hypotension (IDH), a common complication during hemodialysis (HD) could
increase patients' morbidity and mortality. Previous studies considered that some Chinese
herbal medicine (CHM) plays a complementary role in reducing the frequency of IDH. This trial
is aimed to investigate the effect of Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) in patients with
intradialytic hypotension.